Obalon Therapeutics, Inc.
Carlsbad, US · Delaware corporation · 1 known investors
Biotech
Founders & leadership
LH
Les HoweDirector
MB
Mark BristerChief Technology Officer
KH
Kelly Huang, Ph.D.Chief Operating Officer
DF
Douglas FisherDirector
DM
David MoatazediDirector
RD
Raymond DittamoreDirector
SS
Sharon Stevenson, DVM Ph.D.Director
KK
Kim Kamdar, Ph.D.Director
WJ
William J. PlovanicChief Financial Officer
AR
Andrew RasdalPresident and Chief Executive Officer
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$10MraisedAug 2018 · 21 investors · BiotechnologyRule 506(b)
▶$10MraisedAug 2018 · 21 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Les HoweDirector
- Mark BristerExecutive Officer
- Kelly Huang, Ph.D.Executive Officer
- Douglas FisherDirector
- David MoatazediDirector
- Raymond DittamoreDirector
- Sharon Stevenson, DVM Ph.D.Director
- Kim Kamdar, Ph.D.Director
- William J. PlovanicExecutive Officer
- Andrew RasdalExecutive Officer, Director
- Offering amount
- $10M
- Amount sold
- $10M
- First sale
- Aug 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.